NEW YORK, March 15 – Nanogen said Thursday it had shipped a new system designed for targeted gene expression applications for beta testing at two undisclosed US institutions and one in Europe.
Nanogen plans to use the results of the tests to develop new applications for detecting gene expression. Currently the company’s NanoChip system is primarily used do detect and analyze SNPs, short tandem repeats, and mutations.
Nanogen said that its system would differ from most commercial gene expression techniques by allowing researchers to get quantitative, reproducible assays with a known set of genes.
“These scientists will be looking for the capability to perform time-series studies with multiple samples on a single chip or across multiple chips,” Nanogen said in a statement.
Nanogen also said that it had upgraded the loader of its NanoChip system so that it can handle either a 384 or a 96 well plate.
In addition, Nanogen announced that George Bers, vice president of Business Development, left the company to take a job in the Bioresearch Division of Beckman Coulter.
Nanogen did not announce a replacement.